Folliculitis decalvans

L12_FOLLICULITDECALV

androgenetic alopecia:

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L66.2 Hospital discharge: ICD-9 — 7040F Hospital discharge: ICD-8 — 70404 Cause of death: ICD-10 — L66.2 Cause of death: ICD-9 — 7040F Cause of death: ICD-8 — 70404 2 out of 7 registries used, show all original rules.	70
4. Check minimum number of events None	70
5. Include endpoints None	70
6. Filter based on genotype QC (FinnGen only)	70

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L66
Name in latin: Folliculitis decalvans

NAME	L12_FOLLICULITDECALV
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L662
HD_ICD_9	7040F
HD_ICD_8	70404
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L662
COD_ICD_9	7040F
COD_ICD_8	70404
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Folliculitis decalvans based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	658	239	416
Only index persons	549	217	332
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	35.79	40.86	32.78
Only index persons	33.67	39.68	29.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	70	37	33
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	35.30	34.68	36.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
64: Matched controls
641

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

70404

ICD-8 Finland

Diseases of hair and hair follicles, Folliculitis NUD

+∞

39.8

L66.2

ICD-10 Finland

Folliculitis decalvans

+∞

34.5

J01AA04

ATC

lymecycline; systemic

6.9

8.1

D10BA01

ATC

isotretinoin; oral

12.4

8.0

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

29.1

7.8

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

129

2.17

2.20

1.2

1.4

2.3

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.48

1.98

1.4

1.7

—

(3012516) Albumin [Mass/volume] in Urine

153

1.87

1.56

2.2

2.9

11.8

53.9

mg/l

1.49

(3003694) ABO and Rh group [Type] in Blood

153

0.46

1.35

1.3

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

214

1.70

1.31

2.1

1.9

98.9

96.9

pmol/l

0.09

102

(3039443) Prostate specific Ag panel - Serum or Plasma

2.91

1.31

1.6

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

273

1.66

1.24

2.8

4.0

0.0

estimate

—

(3020682) Albumin/Creatinine [Ratio] in Urine

166

1.68

1.15

3.0

3.8

2.1

8.5

mg/mmol

1.32

101

(3007853) Bacteria identified in Skin by Aerobe culture

2.03

1.15

1.4

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

269

1.60

1.11

3.8

5.7

0.0

estimate

—

(3007164) IgA [Mass/volume] in Serum or Plasma

116

1.74

1.10

1.0

1.4

2.4

2.6

g/l

—

(3035350) Ketones [Presence] in Urine by Test strip

271

1.58

1.06

2.7

3.9

0.0

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

206

1.60

1.05

2.7

4.1

—

(3020891) Body temperature

0.00

1.00

0.0

5.2

—

(4010399)

2.05

1.00

1.3

—

(36660697) Celiac disease serology panel - Serum

1.97

0.91

1.0

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

133

1.59

0.85

4.1

6.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

100

1.64

0.81

1.5

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.76

0.78

1.6

1.9

—

(40768443) Skin Pathology biopsy report

2.16

0.76

1.6

1.3

—

(3000330) Specific gravity of Urine by Test strip

2.07

0.74

2.6

4.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.78

0.72

4.6

3.5

81.4

76.8

ng/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.92

0.70

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.92

0.70

3.2

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

139

0.60

0.69

1.1

1.5

1.2

1.0

mg/l

—

112

(3025941) Bacteria identified in Stool by Culture

1.84

0.67

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.61

0.0

1.6

—

(3032080) INR in Blood by Coagulation assay

236

1.39

0.61

3.2

7.0

1.2

inr

—

(3041096) Erythrocytes [Presence] in Urine by Automated

152

1.44

0.61

2.6

3.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.51

0.49

2.3

2.2

15.5

12.9

umol/l

0.84

(3029937) Albumin [Presence] in Urine by Test strip

140

1.38

0.48

3.2

3.9

0.0

estimate

—

(3000494) Fungus identified in Specimen by Culture

1.52

0.47

1.9

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

105

1.42

0.45

1.1

1.3

26.0

8.4

u/ml

—

(21494755) Public health laboratory ask at order entry panel

1.51

0.45

1.4

1.3

—

(3015736) pH of Urine

209

1.31

0.42

2.4

3.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.3

—

11.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

0.00

0.42

0.0

2.7

—

130.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.42

0.0

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

780.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(40768797) Stomach Pathology biopsy report

1.39

0.40

1.1

1.3

—

(3002256) Pathology report gross observation

1.37

0.40

1.2

—

(4094501)

0.00

0.39

0.0

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

177

0.74

0.39

3.6

2.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

119

1.33

0.35

2.9

4.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.67

0.33

1.1

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

363

1.24

0.33

3.8

4.1

—

14.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

158

1.28

0.33

3.8

4.7

27.1

22.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

122

1.29

0.30

1.2

1.6

20.6

21.3

nmol/l

0.07

(3042936) Bacteria identified in Isolate by Culture

1.35

0.28

1.8

1.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.27

0.27

2.7

2.2

2.4

g/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.33

0.26

1.7

1.3

—

(40768804) Tissue Pathology biopsy report

222

1.20

0.23

2.3

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

258

0.84

0.23

5.0

3.8

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.2

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.21

0.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.21

0.0

1.5

—

91.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

2.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.30

0.21

3.0

3.8

1.2

mmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

578

1.27

0.21

12.7

12.8

22.2

21.0

mg/l

0.09

443

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.21

0.0

3.2

—

16.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.21

0.0

5.4

—

29.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

2.6

—

218.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

3.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

323

1.17

0.21

4.1

5.6

10.6

11.3

umol/l

0.28

310

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.20

0.0

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.20

0.0

1.4

—

0.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.20

0.0

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.20

0.0

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

516

1.20

0.20

12.7

13.2

40.5

40.1

0.12

382

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

131

0.81

0.19

4.1

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

234

0.85

0.18

2.4

4.1

15.3

28.9

ng/l

1.77

163

(3023368) Bacteria identified in Blood by Culture

130

0.82

0.17

2.5

4.5

—

(3022145) Colonoscopy Study observation

1.13

0.16

1.4

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

189

1.16

0.16

2.9

3.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

611

1.31

0.15

15.3

15.9

74.8

76.4

umol/l

0.16

611

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

123

1.17

0.14

2.5

3.0

0.8

ug/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.04

0.09

1.6

2.1

—

(3044889) 12 lead EKG panel

394

1.10

0.09

3.4

3.8

—

(1761868) Lipid panel - Serum or Plasma

225

1.10

0.09

2.5

2.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.06

0.09

1.3

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.06

0.09

2.7

8.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

577

1.14

0.09

4.9

4.5

5.9

mmol/l

0.11

530

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.82

0.08

1.2

1.6

—

(3018095) Leukocytes [#/volume] in Urine

196

1.10

0.08

3.4

3.8

95.5

56.8

e6/l

0.17

133

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.11

0.08

1.1

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

376

1.08

0.07

4.8

4.0

—

(40761511) CBC panel - Blood by Automated count

606

1.20

0.07

11.1

11.9

—

(40758558) Short blood count panel - Blood

152

0.90

0.07

4.5

5.8

—

(3021589) Normoblasts [#/volume] in Blood

257

1.08

0.07

8.2

10.5

0.0

e9/l

0.00

199

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

109

1.12

0.06

1.1

1.3

30.7

31.6

iu/ml

—

(3013512) EKG study

182

0.91

0.06

3.4

3.7

—

(36304419) Bacteria [Presence] in Urine

149

1.10

0.06

2.6

3.0

—

(42870588) Differential panel, method unspecified - Blood

179

1.08

0.05

3.3

5.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

151

1.08

0.03

2.2

2.5

352.8

8641.0

umol/l

1.31

135

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

363

1.04

0.01

3.4

3.1

—

(3026008) Bacteria identified in Urine by Culture

161

0.99

0.00

3.9

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

551

0.99

0.00

12.7

85.4

81.5

ml/min/173m2

0.79

447

(3012544) pH of Venous blood

0.98

0.00

4.0

4.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.1

—

(4027681)

0.00

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

50.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3019225) pH of Specimen

0.90

0.00

4.0

2.9

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

2.1

—

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

41.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.3

—

13.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

2.7

—

14.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

0.0

1.2

—

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.0

—

(4306422)

0.00

0.0

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

0.91

0.00

1.3

2.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

0.89

0.00

1.2

2.0

300.5

354.3

nmol/l

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

2.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.02

0.00

1.3

1.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

0.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(4062490)

0.00

0.0

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

0.92

0.00

2.8

3.5

2.2

13.2

ug/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.7

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.0

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.1

—

(4268621)

0.00

0.0

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

2.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

331.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_FOLLICULITDECALV and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_FOLLICULITDECALV.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_FOLLICULITDECALV – Folliculitis decalvans

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Folliculitis decalvans

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints